دورية أكاديمية
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
| العنوان: | Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study |
|---|---|
| المؤلفون: | Akkerman O., Aleksa A., Alffenaar J. -W., Al-Marzouqi N. H., Arias-Guillen M., Belilovski E., Bernal E., Boeree M. J., Borisov S. E., Bruchfeld J., Cadinanos Loidi J., Cai Q., Caminero J. A., Cebrian Gallardo J. J., Centis R., Codecasa L. R., D'Ambrosio L., Dalcolmo M., Danila E., Dara M., Davidaviciene E., Davies Forsman L., De Los Rios Jefe J., Denholm J., Duarte R., Elamin S. E., Ferrarese M., Filippov A., Ganatra S., Garcia A., Garcia-Garcia J. -M., Gayoso R., Giraldo Montoya A. M., Gomez Rosso R. G., Gualano G., Hoefsloot W., Ilievska-Poposka B., Jonsson J., Khimova E., Kuksa L., Kunst H., Laniado-Laborin R., Li Y., Magis-Escurra C., Manfrin V., Manga S., Marchese V., Martinez Robles E., Maryandyshev A., Matteelli A., Migliori G. B., Mullerpattan J. B., Munoz-Torrico M., Mustafa Hamdan H., Nieto Marcos M., Noordin N. M., Palmero D. J., Palmieri F., Payen M. -C., Piubello A., Pontali E., Pontarelli A., Quiros S., Rendon A., Skrahina A., Smite A., Solovic I., Sotgiu G., Souleymane M. B., Spanevello A., Stosic M., Tadolini M., Tiberi S., Udwadia Z. F., van den Boom M., Vescovo M., Viggiani P., Visca D., Zhurkin D., Zignol M. |
| المساهمون: | Akkerman O., Aleksa A., Alffenaar J.-W., Al-Marzouqi N.H., Arias-Guillen M., Belilovski E., Bernal E., Boeree M.J., Borisov S.E., Bruchfeld J., Cadinanos Loidi J., Cai Q., Caminero J.A., Cebrian Gallardo J.J., Centis R., Codecasa L.R., D'Ambrosio L., Dalcolmo M., Danila E., Dara M., Davidaviciene E., Davies Forsman L., De Los Rios Jefe J., Denholm J., Duarte R., Elamin S.E., Ferrarese M., Filippov A., Ganatra S., Garcia A., Garcia-Garcia J.-M., Gayoso R., Giraldo Montoya A.M., Gomez Rosso R.G., Gualano G., Hoefsloot W., Ilievska-Poposka B., Jonsson J., Khimova E., Kuksa L., Kunst H., Laniado-Laborin R., Li Y., Magis-Escurra C., Manfrin V., Manga S., Marchese V., Martinez Robles E., Maryandyshev A., Matteelli A., Migliori G.B., Mullerpattan J.B., Munoz-Torrico M., Mustafa Hamdan H., Nieto Marcos M., Noordin N.M., Palmero D.J., Palmieri F., Payen M.-C., Piubello A., Pontali E., Pontarelli A., Quiros S., Rendon A., Skrahina A., Smite A., Solovic I., Sotgiu G., Souleymane M.B., Spanevello A., Stosic M., Tadolini M., Tiberi S., Udwadia Z.F., van den Boom M., Vescovo M., Viggiani P., Visca D., Zhurkin D., Zignol M. |
| سنة النشر: | 2019 |
| المجموعة: | IRIS Università degli Studi di Bologna (CRIS - Current Research Information System) |
| مصطلحات موضوعية: | Adverse event, Bedaquiline, Delamanid, MDR-TB, Monitoring, Tuberculosi, Antitubercular Agent, Diarylquinoline, Drug Therapy, Combination, Feasibility Studie, Female, Human, Male, Nitroimidazole, Oxazole, Pilot Project, Tuberculosis, Multidrug-Resistant, World Health Organization |
| الوصف: | The World Health Organization launched a global initiative, known as aDSM (active TB drug safety monitoring and management) to better describe the safety profile of new treatment regimens for drug-resistant tuberculosis (TB) in real-world settings. However, comprehensive surveillance is difficult to implement in several countries. The aim of the aDSM project is to demonstrate the feasibility of implementing national aDSM registers and to describe the type and the frequency of adverse events (AEs) associated with exposure to the new anti-TB drugs. Following a pilot study carried out in 2016, official involvement of TB reference centres/countries into the project was sought and cases treated with bedaquiline- and/or delamanid-containing regimens were consecutively recruited. AEs were prospectively collected ensuring potential attribution of the AE to a specific drug based on its known safety profile. A total of 309 cases were fully reported from 41 centres in 27 countries (65% males; 268 treated with bedaquiline, 20 with delamanid, and 21 with both drugs) out of an estimated 781 cases the participating countries had committed to report by the first quarter of 2019. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | ELETTRONICO |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/30953827; info:eu-repo/semantics/altIdentifier/wos/WOS:000469322300013; volume:83; firstpage:72; lastpage:76; numberofpages:5; journal:INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES; http://hdl.handle.net/11585/802282Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065097630 |
| DOI: | 10.1016/j.ijid.2019.03.036 |
| الإتاحة: | https://doi.org/10.1016/j.ijid.2019.03.036Test http://hdl.handle.net/11585/802282Test |
| رقم الانضمام: | edsbas.DE0ED900 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ijid.2019.03.036 |
|---|